BEAUTYFARM MED (02373) Completes Acquisition of 100% Equity in Shanghai Siyanli Industrial

Stock News01-07

The acquisition, which involved the issuance of consideration shares under a special mandate to purchase 100% of the issued shares of Shanghai Siyanli Industrial, has now been finalized. All conditions precedent set forth in the share purchase agreement have been satisfied, with the transaction officially closing on January 7, 2026, in accordance with the agreement's terms and conditions. Following the completion of the acquisition and as of the date of this announcement, the target company has become an indirectly wholly-owned subsidiary of BEAUTYFARM MED. Its operational results and financial position will now be consolidated into the Group's comprehensive financial statements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment